Description
SMA is a synthetic peptide analog structurally related to glucagon-like peptide-1 (GLP-1). It is commonly studied for its interaction with GLP-1 receptors and its role in receptor-mediated signaling pathways.
In laboratory settings, SMA is utilized in research exploring incretin receptor activity, ligand–receptor binding dynamics, and downstream cellular signaling processes.
SMA is provided strictly for laboratory research purposes only. This compound is not approved by the FDA for human or veterinary use and is not intended for diagnosis, treatment, or administration.
